• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Neptune Technologies & Bioressources, Inc. (NEPT)

    1.25 Up 0.07(5.94%) May 27, 3:58PM EDT
    ProfileGet Profile for:
    Neptune Technologies & Bioressources, Inc.
    545 Promenade du Centropolis
    Suite 100
    Laval, QC H7T 0A3
    Canada - Map
    Phone: 450-687-2262
    Fax: 450-687-2272
    Website: http://www.neptunebiotech.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Neptune Technologies & Bioressources Inc., a nutrition company, develops, manufactures, and commercializes marine-derived omega-3 polyunsaturated fatty acids from Antarctic krill. The company also provides custom-made nutraceutical finished products from marine oils, and various other functional ingredients. Its products include Neptune Krill Oil (NKO), which provides omega-3 with superior bioavailability and antioxidant content; NKO Beat improves heart health; NKO Flex provides joint and bone health benefits; and NKO Focus provides brain and vision health. In addition, the company is pursuing opportunities in the prescription drug markets, through its subsidiary, Acasti Pharma Inc., that focuses on the research and development of compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases. It markets and sells its products in Canada, the United States, France, Belgium, Australia, the United Kingdom, and other countries. Neptune Technologies & Bioressources Inc. was founded in 1925 and is headquartered in Laval, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Neptune Technologies & Bioressources, Inc.

    Key Executives 
    Mr. Jim Hamilton ,
    Chief Exec. Officer, Pres and Director
    Mr. Michel Timperio ,
    Head of Strategic Devel.
    Mr. Pierre Lemieux Ph.D., M.D.,
    Chief Operating Officer of Acasti
    Dr. Fotini Sampalis M.D., Ph.D., 53
    Consulting Medical Science Liaison
    Mr. John Morris Moretz , 66
    Special Advisor to the Board, Director and Member of HR & Governance Committee
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders